MTOR and head and neck squamous cell carcinoma: It is a mechanism of resistance to platinum compounds, and the addition of mTOR inhibitors to platinum-based chemotherapy could potentiate the proapoptotic effects of platinum compounds and taxanes in HNSCC cells [8,9,10,11].